PRIMECAP Management acquired 5 Million BeiGene Ltd shares worth $865 Million. That's 0.64% of their equity portfolio (41st largest holding). The investor owns 5.28% of the outstanding BeiGene Ltd stock. The first BeiGene Ltd trade was made in Q2 2017. Since then PRIMECAP Management bought shares sixteen more times and sold shares on eleven occasions. The investor's estimated purchase price is $968 Million, resulting in a loss of 11%.